0001474506-23-000019.txt : 20230110
0001474506-23-000019.hdr.sgml : 20230110
20230110162925
ACCESSION NUMBER: 0001474506-23-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230109
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SKIBSTED RUSSELL
CENTRAL INDEX KEY: 0001308105
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 23521447
MAIL ADDRESS:
STREET 1: 15 TRANQUILITY PLACE
CITY: LADERA RANCH
STATE: CA
ZIP: 92694
FORMER NAME:
FORMER CONFORMED NAME: Skibsted Russell
DATE OF NAME CHANGE: 20041108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200028718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2023-01-09
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001308105
SKIBSTED RUSSELL
6310 TOWN SQUARE
SUITE 400
ALPHARETTA
GA
30005
0
1
0
0
Chief Financial Officer & SVP
Common Stock
2023-01-09
4
A
0
17500
0
A
17500
D
Employee Stock Option (Right to Buy)
2.82
2023-01-09
4
A
0
52500
0
A
2033-01-08
Common Stock
52500
52500
D
The Reporting Person was awarded 17,500 shares of restricted common stock in connection with his service as an executive officer of the Issuer, which shares vest in four equal annual installments beginning January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable anniversary thereof.
Becomes exercisable: (a) with respect to 13,125 options, when the Reporting Person completes 12 months of continuous service with the Issuer, and (b) with respect to the remaining 39,375 options, in equal monthly installments over 36 months beginning one month after the vesting commencement date of January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable vesting date.
/s/ Russell Skibsted
2023-01-10